Search

Your search keyword '"Fillet, Anne-Marie"' showing total 162 results
Start Over Author "Fillet, Anne-Marie"
162 results on '"Fillet, Anne-Marie"'

1. Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study

Author

Cognasse, Fabrice, Hamzeh-Cognasse, Hind, Rosa, Mickael, Corseaux, Delphine, Bonneaudeau, Brigitte, Pierre, Chloe, Huet, Julie, Arthaud, Charles Antoine, Eyraud, Marie Ange, Prier, Amélie, Duchez, Anne Claire, Ebermeyer, Theo, Heestermans, Marco, Audoux-Caire, Estelle, Philippot, Quentin, Le Voyer, Tom, Hequet, Olivier, Fillet, Anne-Marie, Chavarin, Patricia, Legrand, Dominique, Richard, Pascale, Pirenne, France, Gallian, Pierre, Casanova, Jean Laurent, Susen, Sophie, Morel, Pascal, Lacombe, Karine, Bastard, Paul, and Tiberghien, Pierre

Published
2023
Full Text
View/download PDF

5. Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma

Author

Cognasse, Fabrice, primary, Hamzeh-Cognasse, Hind, additional, Rosa, Mickael, additional, Corseaux, Delphine, additional, Bonneaudeau, Brigitte, additional, Pierre, Chloe, additional, Huet, Julie, additional, Arthaud, Charles Antoine, additional, Eyraud, Marie Ange, additional, Prier, Amélie, additional, Duchez, Anne Claire, additional, Ebermeyer, Theo, additional, Heestermans, Marco, additional, Audoux-Caire, Estelle, additional, Philippot, Quentin, additional, Le Voyer, Tom, additional, Hequet, Olivier, additional, Fillet, Anne-Marie, additional, Chavarin, Patricia, additional, Legrand, Dominique, additional, Richard, Pascale, additional, Pirenne, France, additional, Gallian, Pierre, additional, Casanova, Jean Laurent, additional, Susen, Sophie, additional, Morel, Pascal, additional, Lacombe, Karine, additional, Bastard, Paul, additional, and Tiberghien, Pierre, additional

Published
2022
Full Text
View/download PDF

6. Carence en fer chez les donneurs de sang en France : état des lieux et perspectives de prévention

Author

Fillet, Anne-Marie, primary, Leclerc, Carole, additional, Martinaud, Christophe, additional, Malard, Lucile, additional, Le Cam, Sophie, additional, Hejl, Carine, additional, Jacquot, Chantal, additional, Woimant, Geneviève, additional, Chueca, Marine, additional, Bésiers, Christophe, additional, Jacquot, Eric, additional, Morel, Pascal, additional, and Richard, Pascale, additional

Published
2021
Full Text
View/download PDF

7. Modélisation de l’impact du dosage de la ferritine

Author

Richard, Pascale, primary, Leclerc, Carole, additional, Malard, Lucile, additional, Fillet, Anne-Marie, additional, Chanut, Claire, additional, Woimant, Genviève, additional, Jacquot, Chantal, additional, Leleu, Hervé, additional, and Vimont, Alexandre, additional

Published
2021
Full Text
View/download PDF

9. Protocole d’usage thérapeutique du plasma de convalescent de COVID-19–Suivi

Author

Fillet, Anne-Marie, primary, Ferrera-Tourenc, Virginie, additional, François, Marion, additional, François, Anne, additional, Porra, Valérie, additional, Dettori, Isabelle, additional, Resch, Eric, additional, Humbrecht, Catherine, additional, Bourreille, Géraldine, additional, Beguet, Mathilde, additional, Delettre, Fanny, additional, Hervé, Françoise, additional, Pirenne, France, additional, Raba, Michel, additional, Morel, Pascal, additional, and Richard, Pascale, additional

Published
2021
Full Text
View/download PDF

10. Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study.

Author

Richard, Pascale, Fillet, Anne‐Marie, Malard, Lucile, Leclerc, Carole, Chanut, Claire, Woimant, Geneviève, Jacquot, Chantal, Leleu, Henri, Morel, Pascal, and Vimont, Alexandre

Subjects
*IRON deficiency, *FERRITIN, *IRON, *COHORT analysis, *ANEMIA
Abstract

Background and Objectives: Implementing a ferritin testing policy for whole blood (WB) donors may prevent iron deficiency (ID, ferritin <26 ng/mL) and anaemia, but may induce donation losses. As part of a national prevention plan in France, we aimed to estimate its impact on ID, anaemias and WB donations among donors at high risk of ID. Materials and Methods: A micro‐simulation model was developed to evaluate different scenarios compared to the current situation without ferritin testing as a reference scenario. The following scenarios were simulated: a minimum scenario with a 6‐month deferral for donors with absent iron store (AIS, ferritinemia <15 ng/ml), a main scenario with additional delayed invitations for donors with ferritinemia 15–25 ng/ml and a supplementation scenario with additional iron supplementation for 50% of the donors with AIS. Results: In the main scenario, 52,699 WB donations per year were estimated to be lost after 1 year (−8%), falling to 27,687 (−4.7%) after 5 years. IDs and anaemias were reduced by 13.6% and 29.3%, respectively, after 1 year. The supplementation scenario increased the number of prevented IDs and anaemias to 24.1% and 35.4%, respectively, after 1 year, and halved the number of anaemias at 5 years. The latter scenario also had the least impact on the number of donations (−3.2% after 5 years). Conclusion: A ferritin testing policy resulting in delayed donations for ID donors is effective in reducing IDs and anaemias, but significantly impacts the number of donations, thereby posing a self‐sufficiency challenge. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

13. Clinical and Virologic Characterization of Acyclovir- Resistant Varicella-Zoster Viruses Isolated from 11 Patients with Acquired Immunodeficiency Syndrome. (HIV/AIDS)

Author

Saint-Leger, Estelle, Caumes, Eric, Breton, Guillaume, Douard, Danielle, Saiag, Philippe, Huraux, Jean-Marie, Bricaire, Francois, Agut, Henri, and Fillet, Anne-Marie

Subjects
AIDS (Disease) -- Drug therapy, Acyclovir -- Physiological aspects, Drug resistance in microorganisms -- Research, Health, Health care industry
Published
2001

14. Iron deficiency among French whole‐blood donors: first assessment and identification of predictive factors

Author

Fillet, Anne‐Marie, primary, Martinaud, Christophe, additional, Malard, Lucile, additional, Le Cam, Sophie, additional, Hejl, Carine, additional, Chenus, Florence, additional, Woimant, Geneviève, additional, Chueca, Marine, additional, Jacquot, Eric, additional, Besiers, Christophe, additional, Morel, Pascal, additional, Djoudi, Rachid, additional, Garrabé, Eliane, additional, and Gross, Sylvie, additional

Published
2020
Full Text
View/download PDF

16. Predisposing factors for anti-D immune response in D − patients with chronic liver disease transfused with D + platelet concentrates

Author

Burin Des Roziers, Nicolas, Chadebech, Philippe, Malard, Lucile, Vingert, Benoit, Gallon, Philippe, Samuel, Didier, Djoudi, Rachid, Fillet, Anne-Marie, Pirenne, France, Etablissement Français du Sang [Île-de-France Mondor], Laboratoire d'Excellence : Biogenèse et pathologies du globule rouge (Labex Gr-Ex), Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), IMRB - 'Transfusion et Maladies du Globule Rouge' [Créteil] (U955 Inserm - UPEC), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Etablissement Français du Sang [La Plaine Saint-Denis] (EFS), AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Centre Hépato-Biliaire [Hôpital Paul Brousse] (CHB), Hôpital Paul Brousse-Assistance Publique - Hôpitaux de Paris, Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), and CHADEBECH, Philippe

Subjects
[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, [SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB], [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, [SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.BC.IC] Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]
Abstract

International audience; Background: Recent reports have indicated that the risk of anti-D alloimmunization following D-incompatible platelet (PLT) transfusion is low in hematology and oncology patients. We investigated the rate of anti-D alloimmunization in RhD-negative (D- ) patients with chronic liver disease transfused with D+ platelet concentrates (PCs) and the factors involved, at a liver transplant (LT) center.Study design and methods: We reviewed the blood bank database from January 2003 to October 2016. D- patients who had received D+ PLT transfusions were eligible if they had undergone antibody screening at least 28 days after the first D+ PC transfusion, had no previous or concomitant exposure to D+ blood products, and had not received anti-D immunoglobulins.Results: Six of the 56 eligible patients (10.7%) had anti-D antibodies. All had received whole blood-derived PCs. Four of 20 patients (20%) untransplanted or transfused before LT and only two of 36 patients (5.6%) transfused during or after LT produced anti-D antibodies. These two patients were on maintenance immunosuppression based on low-dose steroids and tacrolimus. The factors identified as significantly associated with anti-D immune response were the presence of red blood cell immune alloantibodies before D+ PLT transfusion (p = 0.003), and D+ PLT transfusion outside the operative and postoperative (5 days) periods for LT (p = 0.023).Conclusion: D- patients with chronic liver disease transfused with D+ PLTs before LT are at high risk of developing anti-D antibodies. Preventive measures should be considered for these patients.

Published
2019
Full Text
View/download PDF

25. Risque cardiovasculaire et don de sang – Cardiodon et étude cas-témoin

Author

Fillet, Anne-Marie, primary, Danic, Bruno, additional, Benomar, Djamel, additional, Malard, Lucile, additional, Vidal, Chrystelle, additional, Bésiers, Christophe, additional, Pugin, Aurore, additional, Gueyffier, François, additional, Djoudi, Rachid, additional, Pagadoy, Maïder, additional, Binda, Delphine, additional, and Gross, Sylvie, additional

Published
2019
Full Text
View/download PDF

26. Predisposing factors for anti-D immune response in D- patients with chronic liver disease transfused with D+ platelet concentrates.

Author

Burin des Roziers, Nicolas, Chadebech, Philippe, Malard, Lucile, Vingert, Benoit, Gallon, Philippe, Samuel, Didier, Djoudi, Rachid, Fillet, Anne‐Marie, Pirenne, France, and Fillet, Anne-Marie

Subjects
CHRONICALLY ill, IMMUNE response, RED blood cell transfusion, ERYTHROCYTES, BLOOD products, IMMUNOSUPPRESSION, LIVER transplantation
Abstract

Background: Recent reports have indicated that the risk of anti-D alloimmunization following D-incompatible platelet (PLT) transfusion is low in hematology and oncology patients. We investigated the rate of anti-D alloimmunization in RhD-negative (D- ) patients with chronic liver disease transfused with D+ platelet concentrates (PCs) and the factors involved, at a liver transplant (LT) center.Study Design and Methods: We reviewed the blood bank database from January 2003 to October 2016. D- patients who had received D+ PLT transfusions were eligible if they had undergone antibody screening at least 28 days after the first D+ PC transfusion, had no previous or concomitant exposure to D+ blood products, and had not received anti-D immunoglobulins.Results: Six of the 56 eligible patients (10.7%) had anti-D antibodies. All had received whole blood-derived PCs. Four of 20 patients (20%) untransplanted or transfused before LT and only two of 36 patients (5.6%) transfused during or after LT produced anti-D antibodies. These two patients were on maintenance immunosuppression based on low-dose steroids and tacrolimus. The factors identified as significantly associated with anti-D immune response were the presence of red blood cell immune alloantibodies before D+ PLT transfusion (p = 0.003), and D+ PLT transfusion outside the operative and postoperative (5 days) periods for LT (p = 0.023).Conclusion: D- patients with chronic liver disease transfused with D+ PLTs before LT are at high risk of developing anti-D antibodies. Preventive measures should be considered for these patients. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

30. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non–q-wave acute myocardial infarction

Author

Choussat, Rémi, Montalescot, Gilles, Collet, Jean-Philippe, Jardel, Claude, Ankri, Annick, Fillet, Anne-Marie, Thomas, Danielle, Raymond, Josette, Bastard, Jean-Philippe, Drobinski, Gérard, Orfila, Jeanne, Agut, Henri, and Thomas, Daniel

Published
2000
Full Text
View/download PDF

32. Iron deficiency among French whole‐blood donors: first assessment and identification of predictive factors.

Author

Fillet, Anne‐Marie, Martinaud, Christophe, Malard, Lucile, Le Cam, Sophie, Hejl, Carine, Chenus, Florence, Woimant, Geneviève, Chueca, Marine, Jacquot, Eric, Besiers, Christophe, Morel, Pascal, Djoudi, Rachid, Garrabé, Eliane, and Gross, Sylvie

Subjects
*IRON deficiency, *CART algorithms, *DECISION trees, *LOGISTIC regression analysis, *REGRESSION analysis
Abstract

Background: The objectives of this study are to estimate the prevalence of iron deficiency (ID) among French whole‐blood (WB) donors to identify factors associated with ID and to generate decision trees. Study design and methods: A prospective National multicentre study was performed on WB donors from March 11, to April 5th, 2019. Samples were selected randomly to perform serum ferritin. ID was defined as ferritin value under 26 ng/ml. All results were stratified by sex. Factors associated with ID were analysed using multivariate logistic regression model. CART algorithm was used for decision trees. Results: Eleven thousand two hundred fifty eight WB donors were included. ID was more frequent in women (39·5%) than in men (18·0%). Among 7200 repeated donors, women below 50 yo had a higher risk (OR = 2·37; [1·97–2·85] IC95) than those above 50 yo. Factors associated with ID were: haemoglobin level under the threshold at donation n‐1 except for women and n‐2 donation; a low mean corpuscular haemoglobin at n‐1 and n‐2 donations; a shorter interval since n‐1 donation and between n‐1 and n‐2 donations except for women; and women who had given three or four times in the last year. CART algorithm defined high risk of ID subgroups within three populations of donors, new female donors, repeated male donors and repeated female donors. In these identified subgroups, prevalence of ID was up to 72·1%. Conclusions: Our study showed the high prevalence of ID among French WB donors, identified well‐known and new factors associated with ID and defined algorithms predicting ID in three populations. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

33. Atelier veille prospective du réseau R31

Author

Desqueyroux, Hélène, DUNIER, Muriel, Eilstein, Daniel, Enriquez, Brigitte, Fillet, Anne-Marie, Héry, Michel, Hoummady, Moussa, De Jouvenel, François, Laurent, Louis, Ménager, Marie-Thérèse, ormsby, Jean-Nicolas, Prat, Odette, Rambourg, Marie-Odile, Wendling, Cécile, Agence de l'Environnement et de la Maîtrise de l'Energie (ADEME), INVS, Institut de Veille Sanitaire (INVS), École nationale vétérinaire d'Alfort (ENVA), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Institut national de recherche et de sécurité (Vandoeuvre lès Nancy) (INRS ( Vandoeuvre lès Nancy)), Bureau de Recherches Géologiques et Minières (BRGM) (BRGM), Futuribles, Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Réseau R31, Paulina Cervantes (Anses), Sophie Guitton (Anses), Nathalie Ruaux (Anses), Eric Vidalenc (ADEME), et le groupe de travail « Sciences humaines, sociales et économiques » de l’Anses pour les aspects « société » et « économie », en particulier Valentine Erné-Heintz (Université de Haute-Alsace), Dorothée Marchand (CSTB), Régine Boutrais (Anses), and Benoit Vergriette (Anses).

Subjects
sanitaire, [SDE.MCG]Environmental Sciences/Global Changes, développement durable, technologies vertes, prospective, Veille, [SDE.ES]Environmental Sciences/Environmental and Society
Abstract

Le périmètre de l'exercice décrit dans ce rapport est l'« impact sanitaire sur la population dû au développement de technologies vertes ». La définition retenue pour les technologies vertes est celle du ministère en charge de l’environnement : « Les technologies vertes mesurent, préviennent, limitent ou corrigent les dommages environnementaux à l’eau, l’air et le sol et les problèmes liés aux déchets et aux écosystèmes». L’horizon temporel prospectif, défini pour cet atelier, est de 20 ans.Ce rapport décrit trois activités menées par un groupe de travail, à l'interface veille et prospective. - Un exercice de prospective fondé sur la méthode des scénarios. Il s’agissait de construire cinq scénarios fournissant autant de cadres de référence pour stimuler la réflexion sur les risques sanitaires. A chacun de ces scénarios, on peut associer une typologie de risque sanitaire. On a donc parfois volontairement « forcé le trait » pour faire apparaitre des situations contrastées, fournissant de la matière pour la réflexion sur les risques.- Une action de veille dans le périmètre de l’exercice. Un peu plus de 700 « éléments » ont été rassemblés.- Une recherche sur la manière de coupler « veille et cadres de références scénarios ».

Published
2015

34. Atelier veille prospective du réseau R31: Impact sanitaire sur la population dû au développement de technologies vertes

Author

Desqueyroux, Hélène, DUNIER, Muriel, Eilstein, Daniel, Enriquez, Brigitte, Fillet, Anne-Marie, Héry, Michel, Hoummady, Moussa, De Jouvenel, François, Laurent, Louis, Menager, Marie-Thérèse, ormsby, Jean-Nicolas, Prat, Odette, Rambourg, Marie-Odile, Wendling, Cécile, Agence de l'Environnement et de la Maîtrise de l'Energie (ADEME), Institut National de la Recherche Agronomique (INRA), Institut de Veille Sanitaire (INVS), École nationale vétérinaire - Alfort (ENVA), Direction de l'Evaluation des Risques (DER), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Institut national de recherche et de sécurité (Vandoeuvre lès Nancy) (INRS ( Vandoeuvre lès Nancy)), Bureau de Recherches Géologiques et Minières (BRGM) (BRGM), Futuribles, Direction du financement de la Recherche et Veille scientifique (DfRV), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Direction de l'évaluation des produits réglementés (DEPR), Réseau R31, INVS, École nationale vétérinaire d'Alfort (ENVA), Paulina Cervantes (Anses), Sophie Guitton (Anses), Nathalie Ruaux (Anses), Eric Vidalenc (ADEME), et le groupe de travail « Sciences humaines, sociales et économiques » de l’Anses pour les aspects « société » et « économie », en particulier Valentine Erné-Heintz (Université de Haute-Alsace), Dorothée Marchand (CSTB), Régine Boutrais (Anses), Benoit Vergriette (Anses)., Délégation à l'Expertise scientifique collective, à la Prospective et aux Etudes (UAR), Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de Recherche et de Sécurité (INRS), Superviseur : Louis Laurent, Commanditaire : Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (France), and Type de commande : Auto-saisine

Subjects
sanitaire, [SDV]Life Sciences [q-bio], [SDE.MCG]Environmental Sciences/Global Changes, développement durable, prospective, technologies vertes, Veille, [SDE.ES]Environmental Sciences/Environmental and Society
Abstract

Paulina Cervantes (Anses), Sophie Guitton (Anses), Nathalie Ruaux (Anses), Eric Vidalenc (ADEME), et le groupe de travail « Sciences humaines sociales et économiques » de l’Anses pour les aspects « société » et « économie » en particulier Valentine Erné-Heintz (Université de Haute-Alsace), Dorothée Marchand (CSTB), Régine Boutrais (Anses), Benoit Vergriette (Anses).; Le périmètre de l'exercice décrit dans ce rapport est l'« impact sanitaire sur la population dû au développement de technologies vertes ». La définition retenue pour les technologies vertes est celle du ministère en charge de l’environnement : « Les technologies vertes mesurent, préviennent, limitent ou corrigent les dommages environnementaux à l’eau, l’air et le sol et les problèmes liés aux déchets et aux écosystèmes». L’horizon temporel prospectif, défini pour cet atelier, est de 20 ans.Ce rapport décrit trois activités menées par un groupe de travail, à l'interface veille et prospective. - Un exercice de prospective fondé sur la méthode des scénarios. Il s’agissait de construire cinq scénarios fournissant autant de cadres de référence pour stimuler la réflexion sur les risques sanitaires. A chacun de ces scénarios, on peut associer une typologie de risque sanitaire. On a donc parfois volontairement « forcé le trait » pour faire apparaitre des situations contrastées, fournissant de la matière pour la réflexion sur les risques.- Une action de veille dans le périmètre de l’exercice. Un peu plus de 700 « éléments » ont été rassemblés.- Une recherche sur la manière de coupler « veille et cadres de références scénarios ».

Published
2015

35. Blood products use in France: a nationwide cross-sectional survey

Author

Fillet, Anne-Marie, primary, Desmarets, Maxime, additional, Assari, Suzanne, additional, Quaranta, Jean-François, additional, François, Anne, additional, Pugin, Aurore, additional, Schuhmacher, Anne, additional, Lassale, Bernard, additional, Monnet, Elisabeth, additional, Cabre, Philippe, additional, Legrand, Dominique, additional, Binda, Delphine, additional, and Djoudi, Rachid, additional

Published
2016
Full Text
View/download PDF

37. Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

Author

Sacre, Karim, primary, Carcelain, Guislaine, additional, Cassoux, Nathalie, additional, Fillet, Anne-Marie, additional, Costagliola, Dominique, additional, Vittecoq, Daniel, additional, Salmon, Dominique, additional, Amoura, Zahir, additional, Katlama, Christine, additional, and Autran, Brigitte, additional

Published
2005
Full Text
View/download PDF

38. Early Selection of a New UL97 Mutant with a Severe Defect of Ganciclovir Phosphorylation after Valaciclovir Prophylaxis and Short-Term Ganciclovir Therapy in a Renal Transplant Recipient

Author

Hantz, Sébastien, primary, Michel, Detlef, additional, Fillet, Anne-Marie, additional, Guigonis, Vincent, additional, Champier, Gaël, additional, Mazeron, Marie-Christine, additional, Bensman, Albert, additional, Denis, François, additional, Mertens, Thomas, additional, Dehee, Axelle, additional, and Alain, Sophie, additional

Published
2005
Full Text
View/download PDF

39. Natural Polymorphism of Cytomegalovirus DNA Polymerase Lies in Two Nonconserved Regions Located between Domains Delta-C and II and between Domains III and I

Author

Fillet, Anne-Marie, primary, Auray, Laetitia, additional, Alain, Sophie, additional, Gourlain, Karine, additional, Imbert, Berthe Marie, additional, Najioullah, Fatiha, additional, Champier, Gael, additional, Gouarin, Stéphanie, additional, Carquin, Jocelyne, additional, Houhou, Nadhira, additional, Garrigue, Isabelle, additional, Ducancelle, Alexandra, additional, Thouvenot, Danielle, additional, and Mazeron, Marie-Christine, additional

Published
2004
Full Text
View/download PDF

43. Quantitation of cytomegalovirus (CMV) DNA by real‐time PCR for occurrence of CMV disease in HIV‐infected patients receiving highly active antiretroviral therapy

Author

Gourlain, Karine, primary, Salmon, Dominique, additional, Gault, Elyanne, additional, Leport, Catherine, additional, Katlama, Christine, additional, Matheron, Sophie, additional, Costagliola, Dominique, additional, Mazeron, Marie‐Christine, additional, and Fillet, Anne‐Marie, additional

Published
2003
Full Text
View/download PDF

44. Hepatitis C virus–Epstein‐barr virus interaction in patients with AIDS

Author

Challine, Dominique, primary, Buisson, Marlyse, additional, Cadilhac, Michel, additional, Germanidis, Georgios, additional, Joab, Irene, additional, Eliaszewicz, Muriel, additional, Caumes, Eric, additional, Flahault, Antoine, additional, Fillet, Anne‐Marie, additional, Pawlotsky, Jean‐Michel, additional, and Seigneurin, Jean‐Marie, additional

Published
2002
Full Text
View/download PDF

50. HHV-6 and multiple sclerosis

Author

Fillet, Anne-Marie, primary, Lozeron, Pierre, additional, Augt, Henri, additional, Lyon-Caen, Oliver, additional, and Liblau, Ronald, additional

Published
1998
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results